Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1233, 2009-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Oral sodium phosphates: acute renal failure risk, warns US FDA
Reactions Weekly, Vol. 1, Iss. 1101, 2006-01 ,pp. :
US FDA reports new steps in drug safety
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
The US FDA requires a "new vision of drug safety"
Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. :
US FDA reviewing safety of orlistat
Reactions Weekly, Vol. 1, Iss. 1267, 2009-01 ,pp. :
US FDA reviews safety of Stalevo
Reactions Weekly, Vol. 1, Iss. 1297, 2010-01 ,pp. :